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Abstract 
A new spectrophotometric method is proposed for determination of phenylephrine hydrochloride. 
The  method  is  based  on  the  coupling  of  4-aminoantipyrine  (4-AAP)  with  phenylephrine 
hydrochloride (PEH) to give a new ligand that reacts with copper (II) in the presence of sodium 
tetraborate buffer solution of pH 9.00 at 50 ￿C to give an intense red colored chelate having 
maximum absorption at 480 nm. The optimization of the experimental conditions is described. 
The  method  has  been  used  for  the  determination  of  2.0￿50.0  ￿g/ml  of  PEH.  The  molar 
absorptivity is 5.34￿10
3 L.mol.
-1cm.
-1 and the accuracy of the method is achieved by the value of 
average  recovery  (101.28  %)  and  the  precision  is  supported  by  relative  standard  deviation 
(RSD=1.25  %)  values.  The  results  of  the  method  was  compared  with  those  of  the  standard 
method. The interference of excipients was studied. The mechanism of the chemical reaction has 
been proposed. The proposed method was successfully applied for the determination of the PEH in 
pharmaceutical syrup formulations.   
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Introduction 
 
Phenylephrine  hydrochloride  [PEH,  (R)     
-1-(3-hydroxyphenyl) ￿ 2 - (methylamino) ethanol 
hydrochloride,  C9H13O2N.  HCl],  is  a  white 
crystalline  powder,  and  belongs  to  the  group  of 
medicines  called  sympathomimetics.  It  acts 
stimulating the alpha receptors in certain areas of 
the  body.  It  is  used  locally,  as  decongestant,  for 
non-specific  and  allergic  conjunctivitis,  sinusitis 
and  nasopharyngitis  [1].  PEH  syrup  is  used  for 
relieving  congestion,  cough  and  preventing  or 
treating  symptoms  such  as  runny  nose,  sneezing, 
itching of the nose and throat, watery eyes due to 
colds, flu, or hay fever [2].  
 
Various  analytical  techniques  have  been 
reported  in  the  literature  for  the  analysis of PEH 
including,  titrimetry  [3]  fluorometry  [4],  ion  pair 
chromatography  [5],  High-performance  liquid 
chromatography  [6-8],  micellar  liquid  chromato-
graphy [9], micellar electrokinetic chromatography 
[10],  capillary  zone  electrophoresis  [11,12]  and 
flow  Injection  analysis  with  chemiluminescence 
detection [13]. 
 
Different  spectrophotometric  procedures 
have  been  reported  for  determination  of  PEH 
including  the  formation  of  ion-pair  complexes 
between  the  drug  and  alizarine,  alizarine  red  S, 
alizarine yellow G or quinalizarine [14], ninhydrin 
in  sulfuric  acid  [15],  nitrobenzene  derivates  in 
acetonitrile  medium  [16],  oxidative  coupling  with 
4-aminoantipyrine  in  the  presence  of  potassium 
ferricyanide  or  sodium  periodate  [17,18], 
diazotized p-nitroaniline or 2-aminobenzothiazol in 
alkaline medium [19,20], forming a charge transfer 
complex with chloranil or haematoxylin in alkaline 
medium  [21,22]  and  uranyl  (II)  ion  forming  a 
complex at pH ≤ 7 [23]. 
 
The present research aims to developing a 
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sensitive,  simple  and  accurate  spectrophotometric 
method for the determination of PEH based on its 
coupling  with  4-aminoantipyrine  (4-AAP)  to    
give  a  new  ligand  that  reacts  with  copper  (II)  to 
give  intense  red  colored  chelate.  The            
method  was  applied  for  determining                  
PEH  in  pure  and  pharmaceutical  formulations  as 
syrup. 
 
Experimental 
Apparatus 
 
All  absorption  measurements  were  made 
on  double-beam  spectrophotometer  Shimadzu 
(UV-160A)  and  1-cm  optical  silica  cells.           
The  pH  of  the  solutions  were  measured  by 
HANNA  (pH211)  Microprocessor  pH              
meter.  Heating  of  solutions  is  carried  out  on  a 
water bath. 
 
Reagents 
 
  All  reagents were of analytical grade and 
obtained from Fluka and BDH companies. A 1000 
￿g/ml  solution  of  phenylephrine  hydrochloride 
(PEH)  (provided  from  Sammara  drug  industries; 
SDI,  Iraq))  is  prepared by dissolving appropriate 
amount  of  PEH  in  small  amount  of  ethanol  and 
diluted  to  the  appropriate  volume  with  distilled 
water,  the  solution  was  stored  in  amber  colored 
bottle  and  kept  in  refrigerator.  The  solution  was 
diluted as needed. Solutions of copper sulphate of 
0.1  %,  4-aminoantipyrine  (4-AAP)  of  1  %  and 
sodium hydroxide of 0.05 M concentrations were 
prepared by dissolving accurate weight in distilled 
water  in  addition to the borate buffer solution of 
pH 9.00.  
 
Procedure 
 
Aliquots  containing  2￿50  ￿g/ml  of  PEH, 
in final dilution, were transferred into a series of 
10-ml volumetric flasks, followed by addition of 3 
ml of 1 % 4-AAP, 1 ml of 0.1 % copper sulphate 
and 0.75 ml buffer solution of pH 9.00. The red 
colored  mixture  was  placed  in  water  bath    
adjusted  at  50  ￿C  for  25  min,  cooled  and         
make  up  the  solution  to  10  ml  with              
distilled  water,  the  absorbance  values  were 
measured  at  480  nm  against  the  reagent  blank 
solution. 
Analysis of syrup 
 
The  appropriate  volume  of  the  syrup 
containing  PEH  equivalent  to  5  mg  was 
transferred  into  a  100  ml  measuring  flask, 
diluted,  filtered  and  made  up  to  the  mark  with 
distilled  water.  An  aliquot  of  the  solution  was 
analyzed, as described earlier.  
 
Results and Discussion 
 
Optimum reaction conditions affecting the 
reaction of phenylephrine with 4-AAP and copper 
sulphate were studied.  
 
Absorption spectrum  
 
PEH  reacts  with  4-AAP  and  copper 
sulphate  in  the  presence  of  sodium  hydroxide 
when  heated  for    min  at  50  ￿C  to  give  a  red 
colored  complex.  The  absorption  spectrum  under 
optimum conditions shows a maximum at 480 nm, 
whereas  the  reagent  blank  give  no  absorption  at 
this wavelength (Fig. 1). 
 
 
 
Figure 1. Absorption spectra of (a) PEH (35 ￿g/ml) complex with 
4-AAP and Cu(II) against reagent blank and (b) reagent  blank 
against distilled water under optimum conditions. 
 
Effect of pH  
 
  The effect of pH on the absorption of the 
complex  formed  by  the  reaction  of  PEHwith  4-
AAP  and  Cu(II)  was  studied  at  different    pH  of  
HCl  or  NaOH  in  the  range  2.70-11.45.  It  was 
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pH 9.00 (Fig. 2). Therefore different buffers of pH 
9.00  were  prepared  using  carbonate,  bicarbonate 
and borate buffers to investigate the sensitivity of 
the  4-AAP-PEH￿Cu(II)  complex.  It  was  found 
that borate buffer solution increased the sensitivity 
of the complex. However; the optimum amount of 
borate buffer solution of pH 9.00 has been studied 
and  (Fig.  3)  shows  that  0.75  ml  is  the  optimum 
amount  which  is  recommended  in  the  subsequent 
experiments. 
 
 
 
Figure  2.  Effect  of  pH  on  the  absorption  intensity  of  PEH          
(25 ￿g/ ml)-4-AAP-Cu(II) complex. 
 
 
 
 
Figure  3.  Effect  of  borate  buffer  solution (pH9) amount on the 
intensity of PEH (25 ￿g/ml)-4-AAP-Cu(II) complex. 
 
Effect of  4-AAP reagent concentration 
 
The effect of changing the 4-AAP reagent 
concentration  on  the  absorbance  of  solution 
keeping a fixed amount of the drug, Cu(II) and pH 
9.00  was  studied.  It  was  found  that  absorbance 
increases  with  increasing  4-AAP  concentration 
and reached its maximum value on using 3 ml of 1 
%  4-AAP  (Fig.  4).  This  condition  is  used in the 
subsequent experiment.   
 
 
Figure 4. Effect of 1% 4-AAp reagent amount on the absorption 
intensity of 25 ￿g/ml PEH in the presence of Cu(II). 
 
 
Effect of CuSO4.5H2O concentration 
 
  The  chelating  complex  formation  reached 
its  maximum  when  1ml  of  0.1% of CuSO4.5H2O 
solution were added to a mixture containing a fixed 
amount  of  PEH,  4-AAP  and  pH  9.00,  (Fig.  5), 
therefore,  this  amount  was  used  in  the  procedure 
since it gives high sensitivity and minimum blank 
value. 
 
 
Figure 5. Effect of CuSO4 5H2O concentration on the absorbance 
of 25 ￿g/ml PEH. In the presence of 4-AAP. 
 
 
Effect of temperature and reaction time 
 
  The  reaction  time  was  determined  by 
following  the  color  development  at  room 
temperature  and  at  different  temperatures      
ranged  between  22￿60￿C  in  thermostatically        
controlled  water-bath.  The  absorbance  was 
measured  at  5  and  10  min  intervals  against     
reagent  blank  treated  similarly.  It  is  evident       
from  (Fig.  6)  that  the  formation  of  stable       
colored  complex  for  PEH  was  achieved             
after  50  min.  at  40  C.  Hence,  this         
temperature  and  time  was  selected  for  further 
investigations.  Pak. J. Anal. Environ. Chem. Vol. 11, No. 1 (2010) 
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Figure  6.  Effect  of  temperature  and  developing  time  on  the 
absorbance of 20 ￿g/ml PEH. 
 
 
Effect of order of addition 
 
From the experiments in which the reagent 
was  added  in  all  possible  sequences,  it  was 
concluded  that  the  maximum  absorbance  is 
attained  only  with  the  following  order:  PEH  - 
4AAP - Cu(II) ￿ pH 9.00. 
 
Quantification 
 
       In order to investigate the range in which the 
colored  complex  adhere  to  Beer's  law,  the 
absorbance  of  the  complex  was  measured              
at  ºmax  for  a  series  of  solutions  containing 
increasing  amounts  of  PEH  drug  (Fig.  7)  at 
optimum  conditions.  The  validity  of               
Beer￿s  law,  molar  absorptivity  and  Sandell's 
sensitivity values were evaluated and are given in 
(Table1),  indicated  that  the  method                        
is  sensitive.  The  proposed  method                
showed  excellent  linearity  for  the            
determination  of  PEH  drugs  with  a  good 
correlation  coefficient  (0.9989).  The  relative 
standard  deviation  (RSD)  and  accuracy       
(average  recovery  %)  for  the  analysis                    
of  six  replicates  of  each  three  different 
concentrations  of  PEH  (7.5,  25  and  40  ￿g/ml) 
indicated  that  the  method  is  precise                     
and  accurate.  Limit  of  quantitation                  
(LOQ)  is  determined  by  taking  into               
account  the  ratio  of  standard  deviation  of            
the  blank  with  respect  to  water  and                      
the  slope  of  calibration  curve    multiplied               
by  a  factor  of  10.  However,  LOD  is  well           
below   the   lower   limit of   Beer's law   range. 
 
 
Figure 7. Calibration graph of PEH drug. 
 
 
Table 1. Summary of optical characteristics and statistical data for 
theproposedmethod. 
 
Parameter  Values of method 
Beer's law limits (￿g.ml
-1)  2-50 
Molar absorptivity (l.mol
-1. cm
-1)  5.357￿10
3 
LOD (￿g/ml)  0.1251 
LOQ (￿g/ml)  0.3812 
Average recovery (%)**  101.28 
Correlation coefficient  0.9989 
Regression equation (Y)*   
Slope, a  0.0322 
Intercept, b  0.0263 
RSD**  1.25 
Average recovery %  99.78 
 
*  Y = ax+ b, where x is the concentration of PEH in ￿g/ml. 
** Average of six determinations. 
 
Interferences 
 
  The  extent  of  interfering  by  some 
excipients  which  often  accompanied  
pharmaceutical  preparations  were  studied  by 
measuring  the  absorbance  of  solutions  containing 
20 ￿g/ml of PEH and various amounts of diverse 
species  in  a  final volume of 10 ml. It was found 
that  the  studied  excipients  do  not  interfere  in  the 
determination of PEH in its dosage forms. Vitamin 
C showed an interference effect when present in a 
large  excess,  this  may  be  attributed  to  the    
reduction of Cu (II) to Cu (I) by vitamin C [24]. 
An  error  of  5.0  %  in  the  absorbance             
readings  was  considered  tolerable. Typical results 
are given in Table 2. 
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Table 2. Effect of excipients for assay of PEH. 
 
Recovery %* of 20 g/ml of PEH per 
￿g/ml excipients added in  Excipients 
 
25  50  100  250 
Glucose  99.25  103.75  101.25  101.00 
Lactose  98.75  100.50  100.62  100.75 
Starch maize  98.25  99.00  99.30  102.00 
Acacia  102.00  100.87  103.75  105.50 
Talc  99.00  100.62  103.50  103.00 
Sodium chloride  102.50  100.62  100.75  100.57 
Glycerin  103.25  103.07  103.37  105.75 
Vitamin C  100.75  81.25  65.00  53.75 
 
* Average for three determinations 
 
Analytical applications 
 
  The  proposed  method  was  successfully 
applied to determine PEH in pharmaceutical syrup 
preparations. The obtained results were compared 
statistically by a Student's t-test for accuracy and a 
variance  ratio  F-test  for  precision  with  the 
standard  method  [25]  (depending  on 
potentiometric  titration  of  pure  drug  dissolved  in 
anhydrous acetic acid with perchloric acid) at the 
95  %  confidence  level  with  five  degrees  of 
freedom, as cited in (Table 3). The results showed 
that  the  experimental  t-test  and  F-test  were  less 
than  the  theoretical  value  (t=2.776,  F=6.39), 
indicating that there was no significant difference 
between  the  proposed  method  and  standard 
method. However; there is no method described in 
British  Pharmacopoeia  for  the  assay  of  PEH  in 
syrup  preparations.  The  proposed  method  is 
comparable with other reported methods as shown 
in (Table 4).  
 
Table 3. Assay of PEH in pharmaceutical preparations using the 
proposed method and comparison with the standard method. 
 
Recovery % – RSD
a  Preparation
b  Nominal 
Value 
 
Present 
method                
Standard 
method
c 
Tussiram 
(syrup) 
 
5.0mg/10ml
. 
105.00 – 1.82 
t =1.28 
F =3.91 
 
Tussilet 
(syrup) 
 
2.5mg/5ml 
101.12 –1.47 
t =1.86 
F=2.28 
102.15–1.85 
Pulmocodin 
(syrup) 
 
5.0mg/5ml 
98.86–2.12 
t =2.16 
F=3.20 
 
a Average of six determinations. 
b Marketed by S.D.I Iraq 
c Standard method was applied for determination of pure drug. 
Table 4. Comparison of results for the determination of PEH by 
the proposed method and the reported methods.  
 
Reagent 
used 
ºmax 
(nm) 
 
Beer's 
Law 
(￿g/ml) 
 
 
Molar   
absorp- 
tivity 
(L mol
-1 
cm
-1) 
Applic- 
ation 
Remarks 
 
m-Dinitrob- 
enzene 
 
560 
 
12-175
 
 
1.59 
￿10
3 
 
 
Capsule, 
ampoule 
 
 
Involves 
organic 
medium 
[16] 
 
4-AAP￿
K3[Fe(CN)6] 
503   0.5-
17.5 
  eye and 
nasal 
drops 
 
Involves 
automated 
sequential 
injection 
and 
condensation 
reaction 
[17] 
 
Haematoxylin  620, 
640 
0.5-5  2.38 
￿10
4 
 
Eye 
drops 
Involves 
heating at 
65￿C and 
using of 
organic 
solvent 
[21] 
 
4-AAP-
Cu(II) 
480  2-50  5.357 
￿10
3 
 
syrup  Proposed 
method 
 
Composition of complex 
 
Different  colorimetric  methods  described 
for phenol determination [26,27] are based on the 
reaction  between  phenols  and  4-AAP  to  form 
antipyrine  dyes  where  4-AAP  is  found  to  be  the 
most  sensitive,  fast,  and  precise  colorimetric 
reagent.  4-AAP  reacts  with  phenolic-type 
compounds  according  to  the  reaction  shown  in 
Scheme 1. The reaction product may be any color 
from  red  to  purple  depending  on  the  type  of 
phenolic  compounds.  In  the  present  work,  it  was 
found  that  PEH  reacted  with  4-AAP  in  1:1  ratio 
forming a new ligand having low sensitivity at 480 
nm.  This  sensitivity  has  been  increased  in  its 
complexation  with  Cu(II)  to  give  intense  red 
colored  chelate  as  shown  in  Figure  5.  The 
stoichiometric ratio of the 4-AAP ˰ѧ˰PEH ligand and 
Cu(II)  was  investigated  applying  the  continuous 
variation (Job's) and mole ratio methods [28] using 
equimolar  solutions  of  the  new ligand and 1￿10
-3 
M Cu(II) (Fig. 8). It was found that phenylephrine 
forms  a  dye-coupled  product  with  4-AAP  in  the        
2:1  ratio.  The  reaction  may  proceed  as  given  in 
Scheme 2.   Pak. J. Anal. Environ. Chem. Vol. 11, No. 1 (2010) 
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Figure 8. Continuous variation (a) and mole ratio (b) plots for the dye product of 4-AAP-phenylephrine (110
-3M) with Cu(II) (110
-3M) 
under the optimum conditions. 
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Conclusion   
 
The  proposed  method  is  simple,  fairly 
sensitive  and  economical  when  compared  with 
already  reported  methods  especially  those  which 
are  based  on  non-aqueous  medium  and  expensive 
technique  such  as  chromatographic  instruments 
and do not require any pretreatment of the drugs. It 
has a good accuracy and precision. The method is 
important  for  the  assay  of  pharmaceutical 
preparations  of  PEH  as  syrup,  and  the  results 
suggested that there is no interference with which 
are present in commercial dosage forms except of 
vitamin C present in excessive amount.  
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